March 29, 2024
Bulletin interne de l'Institut Pasteur
See the latest decision and organization memos
• New CeRIAH Administration and Operations Office
The CeRIAH Administration and Operations Office was established on January 1, 2024 in the Center for Research and Innovation in Human Audiology (010720). Céline Quinsac was appointed as head of the office on the same date.
More information in decision memo 1385
• Organizational changes in the Cytometry and Biomarkers UTechS
On January 1, 2024, a number of changes were made to the organizational structure of the Cytometry and Biomarkers UTechS (UTechS CB) (021170):
- The Immuno-monitoring (021171), Single Cell (021172) and Biomarkers (021173) platforms have been closed. Their work will continue as part of the UTechS CB.
- The Cytometry Platform (024490) is no longer part of the UTechS CB and is now affiliated with the Center for Technological Resources and Research (C2RT). It continues to be led by Sophie Novault.
The UTechS CB has been renamed UTechS Single Cell Biomarkers. It continues to be led by Milena Hasan. The term for this UTechS has been extended until December 31, 2024.
More information in decision memo 1391
• External funding that is not permitted or requires special vigilance
To protect the Institut Pasteur's interests, it is important to monitor and restrict the commitments made with some funding bodies.
This memo provides details of external funding bodies that are not permitted and those that require special vigilance. The lists below are not exhaustive and may be updated regularly.
These restrictions apply to projects for which the Institut Pasteur is the direct beneficiary and also to collaborations with other research organizations.